Skip to main content
. 2015 Jun;67:95–105. doi: 10.1016/j.cortex.2015.03.021

Table 1.

General demographic and neuropsychological data for patient subgroups with and without auditory hedonic symptoms.

FTLD
AD
Healthy controls*
Auditory hedonic No auditory hedonic Auditory hedonic No auditory hedonic
General
No. (F:M) 31 (9:22) 25 (15:10) 7 (2:5)†† 10 (5:5) 50 (23:27)
Syndrome: bvFTD/SD/PNFA 19/11/1 3/8/14 NA NA NA
Genetic: C9orf72/MAPT 3/6 4/0 NA NA NA
Age (years) 64.7 (52–79) 64.9 (52–75) 66.3 (60–73) 66.4 (53–80) 67.5 (54–80)
Education (years) 14 (11–21) 15 (11–20) 13 (11–17) 13.9 (12–17) 15.2 (10–18)
Symptom duration (years) 6.1 (3–18) 5.7 (3–21) 6 (4–9) 4.4 (2–6) NA
MMSE 24 (12–30) 19 (1–30) 24 (20–25) 20 (13–30) 29.6 (28–30)
IQ
Verbal 80 (40–119) 82 (55–115) 94 (71–115) 84 (55–108) 120 (101–137)
Performance 101 (74–135) 96 (66–135) 86 (61–125) 84 (57–119) 115 (84–141)
Episodic memory
RMT faces (/50) 31 (2450)a 37 (25–46) 36 (27–43) 32 (23–46) 43 (30–50)
RMT words (/50) 34 (23–49) 37 (18–48) 34 (27–47) 31 (27–42) 48 (39–50)
Semantic processing
BPVS (/150) 110 (2–149) 109 (25–149) 133 (106–146) 124 (52–147) 147 (137–150)
Executive function
Stroop inhibition (180 s) 88 (40–180) 103 (50–180) 135 (42–180) 107 (73–138) 58 (35–103)
Digit span reverse (/12) 4 (0–7) 4 (0–7) 3.5 (2–6) 3 (1–5) 5 (3–7)
Visuospatial
VOSP object decision (/20) 16 (8–20) 16 (3–20) 16.5 (14–18) 16 (11–19) 18 (12–20)

Mean (range) data are shown unless otherwise indicated and maximum scores on neuropsychology tests are also indicated in parentheses. Significant differences (p < .05) between patients and healthy controls are in bold; *historical control group (to reference neuropsychological characterisation of disease groups); †four patients with environmental sound aversion alone, 10 with musicophilia alone, eight with music aversion alone, five with both musicophilia and environmental sound aversion, four with both music and environmental sound aversion (see text, Fig. 1); ††five patients with environmental sound aversion alone, two with both music and environmental sound aversion; asignificantly (p < .05) different from non-symptomatic patients with FTLD; AD, syndrome of Alzheimer's disease led by decline in episodic memory; BPVS, British Picture Vocabulary Scale; bvFTD, behavioural variant of frontotemporal dementia; C9orf72, mutation in open reading frame 72 on chromosome 9; FTLD, frontotemporal lobar degeneration; MAPT, mutation in microtubule associated protein tau gene; MMSE, Mini-Mental State Examination score; NA, not applicable; PNFA, progressive nonfluent aphasia; RMT, Recognition Memory Test; SD, semantic dementia; VOSP; Visual Object and Space Perception battery.